How many insider trades does FilingIQ track for BCAX?

FilingIQ tracks 187 Form 4 insider transactions for BCAX (Bicara Therapeutics Inc.), covering filings from Sep 16, 2024 onwards. 75 of those were filed in the last 90 days.

Are BCAX insiders net buyers or net sellers?

Across the full Form 4 history for BCAX, 6 transactions (3%) were open-market purchases and 57 (30%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does BCAX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is BCAX in?

Bicara Therapeutics Inc. (BCAX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $780.10M.

BCAX insider trading

Healthcare

Bicara Therapeutics Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

187

Last 90 days

Buys / sells

3% / 30%

Market cap

$780.10M

About Bicara Therapeutics Inc.

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody with a domain that binds to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.

Company website: www.bicara.com

BCAX insider activity at a glance

FilingIQ has scored 187 insider transactions for BCAX since Sep 16, 2024. The most recent filing in our index is dated May 8, 2026.

Across the full history, 6 open-market purchases and 57 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on BCAX insider trades is 49.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live BCAX trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding BCAX

Siren, L.L.C.

$42.57M · 2.4% of AUM

Frequently asked

How many insider trades does FilingIQ track for BCAX?: FilingIQ tracks 187 Form 4 insider transactions for BCAX (Bicara Therapeutics Inc.), covering filings from Sep 16, 2024 onwards. 75 of those were filed in the last 90 days.
Are BCAX insiders net buyers or net sellers?: Across the full Form 4 history for BCAX, 6 transactions (3%) were open-market purchases and 57 (30%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does BCAX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is BCAX in?: Bicara Therapeutics Inc. (BCAX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $780.10M.

Methodology & sources

Every BCAX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.